WORLD
Coronavirus vaccine in China produces neutralizing antibodies in early-stage trial
WORLD

Coronavirus vaccine in China produces neutralizing antibodies in early-stage trial

Published: May 22, 2020  |  3 min read, 543 words
WRITTEN BY
Your review will affect the following:
Keep Me Logged InKey PointsA potential coronavirus vaccine developed in China appeared to provoke neutralizing antibodies in dozens of patients in an early-stage clinical trial, an important step in developing a vaccine that might provide immunity to Covid-19.The vaccine candidate also induced binding antibodies in most of the patients within 28 days and appeared to be safe and well-tolerated, according to the findings of the phase one trial published Friday in The Lancet."These results represent an important milestone," Wei Chen, a professor at the Beijing Institute of Biotechnology and... READ MORE
CRITIC
cnbc.com
Outlet Rating
cnbc.com
img-contested
53%
Critic Reviews: N/A
USER
cnbc.com
Outlet Rating
cnbc.com
img-trusted
64%
User Reviews: N/A
TOP REVIEWS
There are no reviews yet.

CRITIC REVIEWS

There don't seem to be any reviews yet.

USER REVIEWS

There don't seem to be any reviews yet.